Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaFrancesco Lo‐Coco, Uwe Platzbecker, Hartmut Döhner et al.|New England Journal of Medicine|2013Cited by 1.6k
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel Á. Sanz, Francesco Lo‐Coco, Pierre Fenaux et al.|Blood|2019Cited by 655
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialUwe Platzbecker, Christian Thiede|Leukemia|2011Cited by 395
Clonal architecture of chronic myelomonocytic leukemiasRaphaël Itzykson, Éric Solary, Olivier Kosmider et al.|Blood|2013Cited by 268
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Théo de Witte, Simona Iacobelli et al.|Journal of Clinical Oncology|2017Cited by 248